| Dr Charles Lindsey Miller, MD | |
|
1125 N College Ave, Fayetteville, AR 72703-1908 | |
| (479) 713-8308 | |
| Not Available |
| Full Name | Dr Charles Lindsey Miller |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 1125 N College Ave, Fayetteville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467469957 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | C-3118 (Arkansas) | Secondary |
| 207R00000X | Internal Medicine | C-3118 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles Lindsey Miller, MD 1125 N College Ave, Fayetteville, AR 72703-1908 Ph: (479) 713-8308 | Dr Charles Lindsey Miller, MD 1125 N College Ave, Fayetteville, AR 72703-1908 Ph: (479) 713-8308 |
News Archive
A new report by the National Academies of Sciences, Engineering, and Medicine proposes a strategy that the U.S. Environmental Protection Agency should use to evaluate the evidence of adverse human health effects from low doses of exposure to chemicals that can disrupt the endocrine system.
By injecting multiwalled carbon nanotubes (MWCNTs) into tumors and heating them with a quick, 30-second zap of a laser, a multi-institutional team of researchers from the Wake Forest University School of Medicine (WFUSOM), Wake Forest University Center for Nanotechnology and Molecular Materials, Rice University, and Virginia Polytechnic Institute and State University has developed a new type of therapy that effectively kills kidney tumors in nearly 80% of treated mice. Researchers say that the findings, which were published in the Proceedings of the National Academy of Sciences of the United States of America, suggest a potential future cancer treatment for humans.
Younger parents were much less likely than older parents to say they planned to vaccinate their children and themselves against COVID-19, according to a research letter published online in medRxiv by authors at the Vanderbilt University School of Medicine and Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern University Feinberg School of Medicine.
Chemed Corporation announced today that the Board of Directors has declared a quarterly cash dividend of 16 cents per share on the Company's capital stock, payable on March 19, 2012, to shareholders of record as of February 27, 2012.
› Verified 2 days ago
Lauren Cantwell Paulk, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1706 E Joyce Blvd Ste 2, Fayetteville, AR 72703 Phone: 479-966-9370 | |
David R Crittenden, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1408 E Elmwood Dr, Fayetteville, AR 72703 Phone: 479-442-0759 | |
Kim R Agee, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3344 N Futrall Dr, Fayetteville, AR 72703 Phone: 479-521-8200 Fax: 479-582-7310 | |
Dr. David A Churchill, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3211 N Northhills Blvd, Suite 110, Fayetteville, AR 72703 Phone: 479-571-4338 Fax: 479-571-4015 | |
Dr. Marlan Levan Rhame Iii, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1100 N College Ave, Fayetteville, AR 72703 Phone: 479-443-4301 Fax: 479-587-5929 | |
Waqar M Mehal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12 E Appleby, Suite 101, Fayetteville, AR 72703 Phone: 479-463-4444 Fax: 479-463-4499 | |
Dr. Juan I Lombeida, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3232 N North Hills Blvd, Fayetteville, AR 72703 Phone: 479-587-1700 |